Endoglin

Expression of vascular endothelial growth factor and assessment of microvascular density with CD 34 and endoglin in proliferative endometrium, endometrial hyperplasia, and endometrial carcinoma
O. Erdem, M. Erdem, A. Erdem, L. Memis, G. Akyol

International Journal of Gynecologic Cancer Oct 2007, 17 (6) 1327-1332; DOI: 10.1111/j.1525-1438.2007.00942.x
Prechemotherapy Serum Levels of CD105, Transforming Growth Factor β2, and Vascular Endothelial Growth Factor Are Associated With Prognosis in Patients With Advanced Epithelial Ovarian Cancer Treated With Cytoreductive Surgery and Platinum-Based Chemotherapy
George Bozas, Evangelos Terpos, Dimitra Gika, Alexandra Karadimou, Meletios A. Dimopoulos, Aristotelis Bamias

International Journal of Gynecologic Cancer Feb 2010, 20 (2) 248-254; DOI: 10.1111/IGC.0b013e3181cc25c3
The prognostic value of endoglin (CD105) expression in ovarian carcinoma
C. Taskiran, O. Erdem, A. Onan, O. Arisoy, A. Acar, C. Vural, M. Erdem, O. Ataoglu, H. Guner

International Journal of Gynecologic Cancer Sep 2006, 16 (5) 1789-1793; DOI: 10.1136/ijgc-00009577-200609000-00011

Main menu